FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

DABUR

518.55
+10 (1.97%)
Updated 11:39 11/08 IST

DABUR Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for DABUR
Disclaimer
0% Bullish
0% Bearish

DABUR Buy or Sell - Brokerage Reports

No. of reports in last year
3
No. of analysts
2
Average Consensus Forecast
522.33
Consensus Potential
2.47%
See DABUR Share Price Targets >>

DABUR Ratings

Long term DABUR rating by FrontPage users
4.4/5 (8 Ratings)
Find answers to all your questions on live DABUR message board: Is DABUR buy or sell? Should I buy DABUR shares? Why are DABUR shares falling? Should I invest in DABUR stock?

  1. Home
  2. DABUR Forum

DABUR Share Price Discussion

N
Reputation: 4,801 • Just now
Stock market update: FMCG stocks rise; Emami jumps 5%
The Nifty FMCG index was trading 1.33 per cent at 32041.7.
The Economic Times
Like
Reply
D
Reputation: 3,384 • Just now
DK Finance in NIFTY-50
Trade entered: Sell NIFTY 27AUG20 FUT @11361.95...
Like
Reply
R
Reputation: 1,756 • Just now

Type
Sell
Instrument
RELIANCE AUG20 2060 PE
Entry Price
₹54.65  ₹54.1
Price@Trade
₹54.4
Target Price
₹34
Stop Price
₹64
Valid Till
Aug 11, 2020 3:20 AM
Margin
₹319,900.23 approx for 505 Qty
Status
Waiting for entry
Like
Reply (1)
Latest replies

Update
Entry Price Modified
Price @ Update
₹54.1
Original Entry Price
₹54.65
New Entry Price
₹54.1
J
Reputation: 84,660 • Just now

Type
Buy
Instrument
BANKNIFTY 13AUG20 21900 PE
Entry Price
₹148.4
Price@Trade
₹148.4
Target Price
₹273
Stop Price
₹113
Valid Till
Aug 13, 2020 3:20 AM
Margin
₹148,400 approx for 1000 Qty
Status
Active
Like
Reply
B
Reputation: 7,577 • Just now

Type
Buy
Instrument
GOLD 05OCT20 FUT
Entry Price
₹54,290
Price@Trade
₹54,284
Target Price
₹54,800
Stop Price
₹54,000
Valid Till
Oct 5, 2020 11:20 AM
Margin
₹397,555 approx for 100 Qty
Status
Waiting for entry
Like
Reply
J
Reputation: 84,660 • Just now

Type
Buy
Instrument
BANKNIFTY 13AUG20 21800 PE
Entry Price
₹116.1
Price@Trade
₹116.1
Target Price
₹233
Stop Price
₹89
Valid Till
Aug 13, 2020 3:20 AM
Margin
₹116,100 approx for 1000 Qty
Status
Active
Like
Reply
T
Reputation: 51,265 • Just now

Type
Buy
Instrument
BANKNIFTY 13AUG20 22000 CE
Entry Price
₹313.25
Price@Trade
₹313.25
Target Price
₹400
Stop Price
₹250
Valid Till
Aug 13, 2020 3:20 AM
Margin
₹626,500 approx for 2000 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
NIFTY 13AUG20 11400 PE
Entry Price
₹50
Price@Trade
₹105.7
Target Price
₹120
Stop Price
₹40
Valid Till
Aug 11, 2020 3:20 AM
Margin
₹3,750 approx for 75 Qty
Status
Waiting for entry
Like
Reply
A
Reputation: 414 • Just now

Type
Buy
Instrument
BANKNIFTY 13AUG20 22100 CE
Entry Price
₹265
Price@Trade
₹259.15
Target Price
₹350
Stop Price
₹220
Valid Till
Aug 13, 2020 3:20 AM
Margin
₹66,250 approx for 250 Qty
Status
Waiting for entry
Like
Reply
I
Reputation: 10,618 • Just now

Type
Buy
Instrument
BANKNIFTY 13AUG20 22000 PE
Entry Price
₹180
Price@Trade
₹186.2
Target Price
₹190
Stop Price
₹170
Valid Till
Aug 11, 2020 3:20 AM
Margin
₹900,000 approx for 5000 Qty
Status
Waiting for entry
Like
Reply
S
Reputation: 70 • Just now

Type
Buy
Instrument
NIFTY 20AUG20 11300 PE
Entry Price
₹111.3
Price@Trade
₹111.3
Target Price
₹125
Stop Price
₹100
Valid Till
Aug 20, 2020 3:20 AM
Margin
₹25,042.5 approx for 225 Qty
Status
Active
Like
Reply
V
Reputation: 1,390 • Just now

Type
Buy
Instrument
RELIANCE
Entry Price
₹2,106.75
Price@Trade
₹2,106.75
Target Price
₹2,500
Stop Price
₹2,000
Valid Till
Aug 18, 2020 3:20 AM
Margin
₹1,011,240 approx for 480 Qty
Status
Active
Like
Reply

Type
Sell
Instrument
TITAN
Entry Price
₹1,065.7
Price@Trade
₹1,065.7
Target Price
₹1,054
Stop Price
₹1,069
Valid Till
Aug 11, 2020 3:20 AM
Margin
₹6,394.2 approx for 6 Qty
Status
Active
Like
Reply
N
Reputation: 4,801 • Just now
SBI's 10 ATM safety mantras: Follow these tips to prevent debit card fraud
To avoid any debit card fraud, SBI advises its customers to do ATM transactions in complete privacy.
Moneycontrol
Like
Reply

Type
Buy
Instrument
BANKNIFTY 13AUG20 22100 CE
Entry Price
₹256.6
Price@Trade
₹256.6
Target Price
₹500
Stop Price
₹180
Valid Till
Aug 13, 2020 3:20 AM
Margin
₹128,300 approx for 500 Qty
Status
Active
Like
Reply
D
Reputation: -3,876 • Just now

Type
Buy
Instrument
HDFC
Entry Price
₹1,835  ₹1,840.6
Price@Trade
₹1,840.6
Target Price
₹1,850
Stop Price
₹1,830
Valid Till
Aug 18, 2020 3:20 AM
Margin
₹184,060 approx for 100 Qty
Status
Active
Like
Reply (2)
Latest replies
Dinesh @davdineshm
Just now

Update
Entry Price Modified
Price @ Update
₹1,840.6
Original Entry Price
₹1,835
New Entry Price
₹1,840.6

Update
Trade Entered
Entry Price
₹1,840.6
B
Reputation: 7,577 • Just now

Type
Buy
Instrument
GOLD 05OCT20 FUT
Entry Price
₹54,385
Price@Trade
₹54,392
Target Price
₹54,800
Stop Price
₹54,000
Valid Till
Oct 5, 2020 11:20 AM
Margin
₹397,690 approx for 100 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
Bhanu @bhanu2020
Just now

Update
Exited before entry
Price @ Update
₹54,370
M
Reputation: -8,618 • Just now

Type
Buy
Instrument
BANKNIFTY 13AUG20 22000 PE
Entry Price
₹195
Price@Trade
₹188
Target Price
₹250
Stop Price
₹160
Valid Till
Aug 13, 2020 3:20 AM
Margin
₹97,500 approx for 500 Qty
Status
Active
Like
Reply (1)
Latest replies

Update
Trade Entered
Entry Price
₹195
S
Reputation: 1,543 • Just now

11-08-20
BANKNIFTY 13th AUG PE 22000 (Intraday)
only Above @ 197
Like
Reply

Type
Sell
Instrument
CIPLA
Entry Price
₹781.75
Price@Trade
₹781.75
Target Price
₹771
Stop Price
₹785
Valid Till
Aug 11, 2020 3:20 AM
Margin
₹148,532.5 approx for 190 Qty
Status
Active
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • DABUR - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization72,250.5
    Enterprise Value72,260.79
    Price to Earnings53.73
    Price to Book Value18.2
    Return on Capital Employed0.31
    Return on Equity0.25
    Face Value1
    Dividend Yield0.02
  • DABUR - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    27-May-20ICICIdirect.comBuy520
    18-Oct-19ICICIdirect.comBuy550
    13-Sep-19HDFC SecuritiesBuy497
    23-Jul-19ICICIdirect.comBuy500
    23-Jul-19HDFC SecuritiesBuy470
    DABUR Brokerage Price Target
  • DABUR Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 10515528506.35508.55
    Aug 7507.9513.7506.05512.3
    Aug 6503.95509.6501.3506.8
    Aug 5508.05511.15501503.05
    Aug 4515516.2505.55506.95
  • DABUR Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹492.34
    30 Day Moving Average₹485.05
    50 Day Moving Average₹473.3
    100 Day Moving Average₹463.54
    200 Day Moving Average₹470.07
  • DABUR - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue5,6095,369.840.04
    Operating Profit1,2151,111.370.09
    Profit Before Tax1,3731,294.350.06
    Net Income1,072998.330.07
  • DABUR - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,9694,226-0.06
    Total Liabilities1,6101,6020
    Total Assets5,5795,830-0.04
  • DABUR - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity813926.94-0.12
    Cash from Investing Activity-261-678.94-0.62
    Cash from Financing Activity-493-273.660.8
    Net Cash Flow59-25.66-3.3
  • DABUR - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.180.19
    Return on Equity0.250.27
    Return on Capital Employed0.310.33
  • DABUR - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.03
    3 Year CAGR Growth in Operating Profit0.33
    3 Year CAGR Growth in EBIDTA0.42
    3 Year CAGR Growth in Net Income0.41
    3 Yr CAGR Growth - Diluted EPS0.4
  • DABUR - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.29
    5 Year CAGR Growth in Operating Profit0.68
    5 Year CAGR Growth in EBIDTA0.83
    5 Year CAGR Growth in Net Income0.81
    3 Yr CAGR Growth - Diluted EPS0.8
  • DABUR - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 9 2:21 AM
    B M Khaitan family's shareholding dips further in Eveready Industries and McLeod Russel India
    The Economic Times
    NewsBot
    Aug 9 8:48 AM
    Momentum oscillator indicates Nifty could consolidate; three stocks for short term
    Moneycontrol
    NewsBot
    Aug 9 7:08 AM
    Reduce Dabur; target of Rs 433: HDFC Securities
    Moneycontrol
    NewsBot
    Aug 7 1:26 AM
    Here's what Indians have been spending their cash on during the coronavirus pandemic
    The Economic Times
    NewsBot
    Aug 5 4:16 AM
    Share market update: FMCG stocks flat; Jubilant Foodworks gains 2%
    The Economic Times
    NewsBot
    Aug 4 10:38 AM
    Hold Dabur India; target of Rs 500: Emkay Global Financial
    Moneycontrol
    NewsBot
    Aug 4 1:58 AM
    Buy Dabur India; target of Rs 565: Motilal Oswal
    Moneycontrol
    NewsBot
    Aug 3 8:08 AM
    Hold Dabur India; target of Rs 515: Arihant Capital
    Moneycontrol
    NewsBot
    Aug 3 7:33 AM
    Hold Dabur India; target of Rs 469: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Aug 3 6:43 AM
    Reduce Dabur India; target of Rs 495: Dolat Capital
    Moneycontrol
  • DABUR - Related Communities

    keyboard_arrow_down
    Hindustan Unilever Ltd. NSE: HINDUNIL...
    Marico Ltd. NSE: MARICO | BSE: 531642...
    Colgate Palmolive (India) Ltd. NSE: C...
    Godrej Consumer Products Ltd. NSE: GO...
    Jyothy Labs Ltd. NSE: JYOTHYLAB | BSE...
    Emami Ltd. NSE: EMAMILTD | BSE: 53116...
    Gillette India Ltd. NSE: GILLETTE | B...
    Zydus Wellness Ltd. NSE: ZYDUSWELL | ...
    Kaya Ltd. NSE: KAYA | BSE: 539276 | I...
    Procter & Gamble Hygiene and Health C...
  • DABUR - More Information

    keyboard_arrow_down

    Dabur India Ltd:
    Dabur India Limited is an internationally established top-notch consumer goods company. It operates in the fields of consumer care, food, and various other aspects. Apart from this, the company also sells health supplements under the brand names of Dabur Chywanprash, Dabur Glucose, and Dabur Honey. It also sells digestive goods like Nature care brand products, Pudin Hara and Dabur Hajmola.
    Other than all such consumer goods, the company also provides products like mosquito repellents under the brand name of Odomos, air freshener and toilet cleaner under the brand name Odonil, and under the brand name of DABISCO, it sells natural gums. Besides these products, it also sells specialized beauty goods, in retail stores with a wide range of cosmetics, skincare and hygiene products apart from fashion and beauty accessories under the brand name of NewU. The company was incorporated in the year 1884, and it is based in Ghaziabad in India.
    Company Overview:
    Back in 1979, Dabur Research Foundation was set up. The company commenced its commercial production in its herbal medicine plant in Sahibabad. In 1986, Dabur became a public company. Within the next two years, in 1988, the company ventured into pharmaceutical medicines. The following year it gained more popularity by turning its ayurvedic digestive product to a kid's product under the name of Hajmola Candy. Anmol coconut oil was launched three years after this in 1992.
    The Burman family, responsible for the management of the company, handed over the management to professionals in 1998. In a joint venture, the company formed a new one under the name Dabon International Ltd by partnering with Bongrain International SA, a French company. In 2000, Efarelle Comfort, which is a menstrual pain reliever, was launched by the company. Other than this, they also launched isabgol husk through the brand Nature Care.
    In the next five years, in 2005, through an all-cash deal amounting to Rs 143 crore, the company acquired a leading company"Balsaras Hygiene and Home Products" that provided oral and household care items in India.
    Between the years of 2009-2010, it acquired 20% of the public equity share capital that belonged to Fem Care Pharma Ltd. This brought up their total controlling shares to 92.15% as they already had a predominant share percentage of 72.15 previously. Namaste Cosmeticos Ltd in 2012 turned out to be the company's subsidiary in Brazil. It then went on to expand its range in terms of fruit juices, an excellent example being Real Activ.
    The company in 2015 agreed with SMG (Starcom MediaVest Group). Dabur then introduced salon facial care products for men and women alike under their Oxlife brand name.
    On the 24th of February in 2016, Dabur announced that it had paired up with the Indian Government through a license agreement to launch commercial drugs, Ayush-64, and Ayush-82 for the treatment of Malaria and Diabetes respectively. On the 14th of March in 2017, Dabur India announced that they were launching an on-the-go homey testing lab. This went under the name of Mobile Honey-Testing Lab. This lab could check honey at its source to detect any adulteration and test the purity of the product.
    Currently, Dabur is a home brand that has been able to continue with most of these products. It also provides hair oils presently under multiple brands like Vatika, Dabur Amla, and Almond. It also offers a diverse range of skincare products under DABUR Fem brand, Oxylife brand as well as Dabur Gulabari, a popular product. Besides all such products, it also offers products on Amazon online worldwide, where consumers can avail Dabur Red Paste, Meswak, Dabur Lal Dant Manjan and Dabur Babool. Its diversified range of fruit juices now offers multiple products under the brand name of Real and Real Activ.
    How Dabur India Ltd is categorised under Personal Care Sector and Personal Care Industry:
    The personal care industry comprises of companies that derive its business by producing consumer products that are used for personal hygiene and beautification. Few of the products that are labelled as personal care are wet wipes, toilet paper, toothpaste, talcum powder, moisturizer, perfumes, cosmetic products, shaving creams, razors and more. The demand for Personal Care Sector is extremely diversified and can be bifurcated into personal care products and personal care devices. Personal care appliances have become standard across the globe in the last few years owing to the invasion of new and innovative tools in the market every year.
    Dabur India Ltd is categorised under Personal Care Sector and Personal Care Industry. The global market for personal care Sector is anticipated to witness extraordinary growth over the upcoming years owing to the swelling disposable income of consumers, thus allowing them to spend on extravagance personal care products. While the personal care cosmetic segment for women is a leading category, the initiation of the men’s product line for grooming has reinforced the growth of the market extensively.
    Dabur India Ltd Competitors and Sector Peers:
    Ador Multiproducts Ltd.ADOMUL
    Amar Remedies Ltd.AMAREM
    Bajaj Consumer Care Ltd.BAJCOR
    Colgate Palmolive Ltd COLPAL
    Emami Ltd.EMALTD
    Fem Care Pharma Ltd.[Amalgamated]FEMCAR
    Gillette India Ltd.GILIND
    Godrej Consumer Products Ltd.GODRCO
    Godrej Industries Ltd.GODIND
    Hindustan Unilever Ltd.HINUNI
    J L Morison (India) Ltd.JLMORJH
    S Svendgaard Laboratories Ltd.JHSSVE
    Jyothy Consumer Products Marketing Ltd.[Amalgamated]HENIND
    Jyothy Labs Ltd.JYOLAB
    Kaya Ltd.KAYLTD
    Magna Industries Exports Ltd.MAGNIN
    Marico Ltd.MARLTD
    Paramount Cosmetics (I) Ltd.PARCOS
    Polo Queen Industrial and Fintech Ltd.SEARIN
    Procter & Gamble Hygiene & Healthcare Ltd.PROC
    Rajnish Wellness Ltd.RAJWEL
    RayBan Sun Optics India Ltd.RAYSUN
    Safal Herbs Ltd.PARHER
    Synergy Cosmetics (Exim) Ltd.JYOCOS
    Tiaan Ayurvedic & Herbs Ltd.RACCAP
    Velvette International Pharma Products Ltd.VELINT
    Wellness Noni Ltd.RGNSEC
    Zydus Wellness Ltd.CARNUT
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020